ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
How ASX shares can help you retire early
Growth Shares
Top brokers name 3 top ASX growth shares to buy now
Healthcare Shares
Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell?
Blue Chip Shares
3 high-conviction ASX 200 shares I'd buy in June
Broker Notes
Where to invest $10,000 in ASX 200 shares this month
How to invest
How ASX 200 stocks and ASX ETFs can be combined to build the perfect portfolio
How to invest
How to generate $52,000 of passive income from ASX shares
How to invest
How I profited from the last share market crash (and what I could do better next time)
How to invest
How $250 a month in ASX shares could turn into $500,000
Growth Shares
The ultimate ASX growth shares to buy with $5,000
Growth Shares
Where to invest $1,000 into ASX shares in June
Broker Notes
Top brokers name 3 ASX shares to buy next week
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
